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Abstract
Chronic venous disease (CVD) is a chronic condition that is associated with venous 
hypertension, vein’s valves damage, venous obstruction, and calf muscle pump impair-
ment. This blood circulatory condition is also characterized by important inflammatory 
changes affecting the skin, the subcutaneous tissue and the muscles, which are probably 
triggered by blood stasis and venous edema. With disease progression, severe ulcerative 
skin damage might occur, which when present represent the more severe stage of this 
condition. CVD has a significant economic, social and health impact, mostly due to raised 
morbidity and chronicity.
The treatment of patients with CVD might focus on both the symptoms and second-
ary changes of the disease, such as edema, skin and subcutaneous changes or ulcers. 
Usually, initial treatment of CVD patients involves a non-invasive, conservative treat-
ment to reduce symptoms, treat secondary changes, and help prevent the development 
of secondary complications and the progression of the disease. Complementary, some 
interventional or surgical treatments can be undertaken.
There are several conservative treatments to treat and prevent complications associated 
with CVD that have been described in the literature, like manual lymphatic drainage 
(MLD) and  compression, physical exercise, intermittent pneumatic pressure, kinesio tap-
ing, electrical muscle stimulation, transcutaneous electrical nerve stimulation, hydrother-
apy, and health education. Most of these techniques are complementary to compression 
therapy or pharmacological treatment.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
This chapter will address the role of physical therapists in the management of CVD. The 
chapter will begin by reviewing the basic physiopathology of CVD, including the role of 
calf muscle pump. The CEAP classification system and the chronic venous severity score 
will be presented, as these are main tools for clinical assessment of CVD severity. In the 
remainder of the chapter will address the physiological effects and recommendations for 
treating CVD of MLD, based on our clinical experience and own research.
Keywords: chronic venous disease, edema, calf muscle pump, manual lymphatic 
drainage
1. Introduction
The term chronic venous disease (CVD) has been used to describe morphological and func-
tional abnormalities of the venous system of extended duration that are manifested them-
selves by symptoms and/or signs that indicate the need for evaluation and care by health 
professionals [1].
Usually, symptoms of leg heaviness, fatigue, and pain are the first complaints referred by 
patients, which together with varicose veins are present both in mild and severe cases of CVD. 
These complaints combined with structural  changes in superficial, visible veins strongly con-
tribute to a negative self-esteem that also characterizes this disease [2–8]. The diminished 
health-related quality of life (HRQL) seen in CVD is well studied [2, 8–10]. This negative 
impact is so important that the previous view of this condition as an aesthetic problem has 
been abandoned for years.
The socioeconomic burden of CVD is very high. The indirect costs are substantial and are 
associated with the symptoms, functional impairment, emotional disturbances and negative 
impact in HRQL [11]. The direct costs of CVD treatment are almost entirely related to its 
high prevalence, morbidity, and chronicity [11, 12]. In developed countries, around 1–3% of 
the health costs are due to CVD [13]. However, when patients with less severe stages of the 
disease are diagnosed and treated early, the physiopathology course of the disease can be 
prevented or even receded [14].
The severity of CVD is nowadays evaluated based on a multifactorial concept of the disease 
and using the standardized CEAP (Clinical Etiological, Anatomical and Pathological) clas-
sification system. Having a good knowledge of this system is very important to all physical 
therapist and it is important that health professionals use the same nomenclature so that CVD 
severity can be accurately assessed and the best treatment delivered [15].
The treatment of patients with CVD might focus on both the symptoms and secondary 
changes of the disease, such as edema, skin and subcutaneous changes or ulcers. Usually, 
initial treatment of CVD patients involves a non-invasive, conservative treatment to reduce 
symptoms, treat secondary changes, and help prevent the development of secondary compli-
cations and the progression of the disease. Complementary, some interventional or surgical 
treatments can be undertaken [15].
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Manual lymphatic drainage (MLD) is a low-pressure form of skin-stretching massage, 
described as a conservative treatment for CVD [16] and as a coadjutant of other treatments, 
like stockings and surgery [17, 18]. This technique has been proposed for the treatment of 
venous lymphedema associated to CVD [19, 20], before CVD surgery, or to relief symptoms 
[17, 18, 21]. It is suggested by the literature that this physical therapy technique should be 
applied taking into account venous anatomy and that it should increase deep and venous 
flow [22, 23].  Despite controversial evidence regarding the ability of MLD to reduce edema or 
lymphedema, this technique when associated with other treatments, the so-called “lymphatic 
decongestive therapy”, that also includes compression, exercise, and education, may have an 
important role for improving health and functional status in patients with edema associated 
to sport injury or related to breast cancer surgery, just to mention two common situations [21, 
24–26].
This chapter will address the role of physical therapists in the management of CVD. The 
chapter will begin by reviewing the basic physiopathology of CVD, including the role of calf 
muscle pump. The CEAP classification system and the chronic venous severity score will be 
presented, as these are main tools for clinical assessment of CVD severity. In the remainder of 
the chapter, we will address the physiological effects of MLD on venous circulation and the 
recommendations for its use in treating CVD.
2. Health and social impact of CVD
2.1. Epidemiology
Chronic venous insufficiency, represents the most severe cases of CVD, and its physiopathol-
ogy is associated with venous hypertension, vein valve damage, venous obstruction, calf mus-
cle pump impairment, inflammation of tissues (skin, subcutaneous tissue, and muscle) and 
veins, alteration of veins morphology and function. This disease is characterized by abnormal 
venous reflux, venous edema, and changes of the skin and subcutaneous tissue, with ulcer 
representing the most severe stage of this condition, and is classified between C
0
 (no signs) 
and C
6
 (active ulcer) CEAP classes [13, 27–32]. Despite some controversies, CVD might exist 
without the presence of signs [3, 13, 33].
The estimated prevalence of CVD varies according to its severity, being around 10, 9, 1.5, and 
0.5% for CEAP clinical levels C
3
 (venous edema), C
4
 (hyperpigmentation or eczema, lipoder-
matosclerosis, or atrophie blanche), C
5
 (healed venous ulcer), and C
6
 (active venous ulcer), 




), appear to affect about 
5% of the population [1]. Milder CVD conditions, like telangiectasiae and reticular veins (C1 
class), have been reported to affect up to 80% of the population, while the incidence of vari-
cose veins (C2 class) has been reported as ranging from 20% to 64% [1].
Despite its frequency in the population, the prevalence of CVD is still underestimated. 
Epidemiological data estimate a wide range of CVD prevalence, varying between 1-17% in 
men and 1-40% in women [34]. In the USA alone, approximately 2.5 million people suffer 
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from CVD [2]. Variation in estimations of CVD prevalence are likely explained by differences 
in gender, age, ethnic group, risk factors and variations in diagnostic criteria and methods [1, 
34]. A study where 91545 participants were evaluated, found a CVD prevalence of 83.6%, with 
63.9% of the subjects classified as C1-C6, and 19.7% as C0. Regarding CVD prevalence accord-
ing to gender, this study showed higher number of men in C0 class, higher number of women 
in C1-C3 classes and equal number of men and women in the more severe groups (C4-C6 
class) [35]. Considering only the cases of varicose veins (C2), prevalence has been shown to 
vary in the range 7-40% in men and 25-32% in women [34].
2.2. Functional and HRQL implications of CVD
Patients with CVD display impaired functional capacity [2, 36] and diminished HRQL [9, 10, 
37, 38]. The severity of CVD, HRQL scores, the clinical signs, and venous ultrasound findings 
of the disease are usually correlated [39].
The impact of CVD on HRQL is primarily seen in the physical items and in the emotional 
domain, but in its severest stages (presence of venous ulcers) the mental dimension might also 
become involved [9]. The impact of severe CVD in HRQL is similar to that of other chronic 
diseases, such as diabetes, cancer, chronic pulmonary disease, and heart failure [9].
Most of chronic leg ulcers are venous in origin [40]. Patients with venous ulcer present severe 
pain, which is in relationship with impaired tissue healing ability, diminished HRQL, low-
ered self-esteem, and poor social interactions [2]. The psychological effects of CVD may be not 
strictly related with ulceration itself but can else be associated with the symptoms caused by 
this type of wound (80.5-69.4%), altered appearance and esthetical concerns (66.7%), lack of 
sleep (66.6%), functional impairment (58.3%), and disappointment with treatment outcomes 
(50%) [2]. Also, patients with uncomplicated varicose veins often have severe symptoms 
that adversely affect their HRQL, irrespectively of the severity of the disease, refuting the 
view that this disease is mostly an aesthetic problem [8]. Estimates indicate that near 30% of 
patients with symptomatic varicose veins, who may not have had their clinical venous condi-
tion diagnosed or treated, display symptoms suggestive of a depressive illness [41].
In this disease, 49% of men and 62% of women have symptoms related to CVD [33], like pain, 
itching, tingling, cramps, restless legs, swelling, heaviness, and fatigue [3, 8]. A recent survey 
reveals that 14.9% of the general Greek population refers symptoms and/or present signs 
related to CVD [42].
The number of symptoms reported by patients with CVD varies but are usually several [4, 5, 
8]. Importantly, the number and severity of symptoms are not strictly related to CVD sever-
ity and, sometimes, strong symptoms, and those that have the largest impact on HRQL, are 
present in less severe cases [8]. Nevertheless, despite possible indication for surgery, some 
studies suggest that the majority of the symptoms in patients with varicose veins are nonve-
nous related [5]. Indeed, it seems very difficult to separate venous from nonvenous causes of 
symptoms in CVD [6].
Clinical Physical Therapy146
Several  studies show the presence of both neuropathic and nociceptive pain in patients with 
CVD [4, 43]. Nevertheless, patients with CVD may present other comorbidities that make it 
difficult to isolate the CVD-related pain [43, 44].
Approximately one-third of people with CVD report to be a burden going out of home and 
participating in social events, and that they avoid wearing clothes exposing their legs or going 
on vacations to very warm places [42]. According to self-reports, functional status is dimin-
ished in these patients [36, 39] also because of some physical dysfunctions, like abnormali-
ties in gait [45], impaired balance, peripheral neuropathy [43, 46] weak leg muscles (plantar 
flexion and dorsiflexion muscles) [29, 30, 45], or diminished ankle range of motion [10, 30, 
47]. These dysfunctions are also associated with impaired muscle pump function in the lower 
extremity [43], an important risk factor for venous ulceration [48].
2.3. Socioeconomic impact of CVD
Severe CVD has a significant economic impact, mostly due to raised morbidity. Over the last 
decade, neither CVD-associated and inflation-adjusted mean hospital charge, nor length of 
hospital stay decreased, possibly as a result of poor advancements in prevention and treat-
ment of this disease [49]. It is estimated that 4.6 million of working days per year are lost as 
a result of CVD [40]. Painful leg ulcers, the odor, the dressing, the frequent need for treat-
ment, with their associated restrictions and social isolation result in a heavy psychosocial 
burden [50]. In severe CVD, venous ulcers require wound care, compression, chemical and 
mechanical debridement, and, in frequent cases, antibiotic therapy [49]. While ulcer treatment 
is usually done in outpatient settings, in some particularly critical situations it may require 
hospitalization [40]. Western European countries spend 1.5-2% of their annual health budget 
in the treatment of this disease [51]. The economic burden is not just associated with clinical 
visits and outpatient treatments, but also with travel time, loss of work hours for patients and 
family, and physiological impairment related to analgesic and antibiotic use [49]. Limb ampu-
tation is a radical outcome of this disease, although in many of cases these are also related 
to comorbidities, for instance diabetes and arterial vascular disease [49]. Other important 
complications, such as hemorrhage, thrombosis and pulmonary embolism, also compound 
the unhealthy profile of these patients [42]. Deep venous thrombosis may cause chronic con-
ditions like post-thrombotic syndrome and CVD, increasing the costs of the treatment [49]. 
Preventing deep venous thrombosis and complications is one of the most important aims for 
reducing socio-economic burden associated to CVD [49].
The chronic nature of the problem results in long-term costs and the frequent recurrences, 
together with the poor effectiveness of current treatments, further expand the cost of this 
disease [40].
Despite its cost, the efficacy of the pharmacological treatment of CVD is usually poor, and 
should be combined with other strategies, such as the use of elastic garment compression [33]. 
Similar procedures are recommended following surgery and sclerotherapy, in which cases 
post-operative compression therapy and health education are crucial for treatment success 
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[42, 52]. There are several risk factors associated with CVD that patients should be informed 
of by the health professionals, like the use of hormonal contraceptives by women, daily rou-
tines (sitting or standing), pregnancy, age, obesity and heredity factors (i.e., family history) 
[1, 37, 42, 49, 53]. Also important, advice regarding behavioral changes, engaging in so-called 
venous exercises and the proper use of the health care services, should be offered to CVD 
patients [42]. Getting the right advice from health care professionals is an important measure 
for preventing and managing CVD [42].
Because of the wide spectrum of factors that cause functional impairment in these patients 
and the high costs of treatment [2, 3, 8], the prevention of CVD by educational and prophylac-
tic interventions has been shown to be clinically cost-effective, by avoiding disease progres-
sion to the last stages [49, 54].
3. Pathophysiology of CDV
Near 60% of blood volume flows is in the venous system, the majority of it in the lower limbs 
and in the cutaneous circulation, and near 20-25% occupies the splanchnic circulation [55]. 
The venous system returns the blood to the heart and is a low-pressure, slow-velocity, large-
volume and low-resistance vascular system [1].  Venous return results from the interaction 
of diverse mechanisms, like a central pump (respiratory cycle and heart), a pressure gradi-
ent, a peripheral venous pump, and veins valvular system [43]. The venous volume in the 
lower limb is the result of the interaction between these mechanisms and reflects the balance 
between blood inflow and outflow [1].
CVD is caused by venous hypertension, valvular insufficiency, and/or blood reflux [56–58]. 
Venous hypertension might be accompanied by outflow obstruction [57] and can affect the 
superficial, perforator, and deep veins [3, 58]. Insufficient lymphatic drainage or a dysfunc-
tion of calf muscle pump are very often associated with this disease [59]. Venous hypertension 
is related to structural (veins and valves), hemodynamic (obstruction, reflux, stasis), biome-
chanical (calf muscle pump strength and ankle range of motion) and biochemical factors (leu-
cocyte-endothelial process inflammation) [57, 58].
The exact mechanisms behind the development of CVD are not clear yet [57, 60]. The major 
hypothetical sequence of events places venous hypertension as the trigger, causing inflam-
mation of the veins’ wall and of vein valves, with inflammation, as the condition aggravates, 
spreading to the skin and the muscles, causing dermal changes, like hyperpigmentation, sub-
cutaneous tissue fibrosis (lipodermatosclerosis), and tissue necrosis and ulceration [20, 51, 57, 
59] in the most severe cases [60].
Venous obstruction occurs because of the triad: blood stasis, changes in the vessel wall, and 
hypercoagulability [61]. This may occur as a phlebitis (obstructions of superficial venous sys-
tem) or as deep venous thrombosis (obstructions of deep venous system), and can be diagnosed 
as acute or chronic [12]. The acute deep venous thrombosis may cause nociceptive pain, swell-
ing and tenderness, and both phlebitis and deep venous thrombosis must be confirmed by 
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venous ultrasonography [57]. The ensuing venous hypertension then opposes venous return, 
leading to luminal hypoxemia and vein wall distension, which impairs perfusion and causes 
endothelial hypoxia and leukocyte invasion of the vein’s media [61]. A progressive remodeling 
process is then triggered consisting of hypoxemia-related venous/capillary wall injury, leuko-
cytes accumulation and adhesion, progressive blockage of capillary blood flow, and ongoing 
damage of subcutaneous tissues and skin (lipodermosclerosis and skin ulceration) [62].
Usually, venous reflux and obstruction occur together [57]. Following obstruction, venous 
recanalization occurs and blood flow through the vein is restored [61]. However, lysis of 
the clot or thrombus is usually only partial and the residual thrombus might undergo fibro-
sis that may completely obstruct the lumen of the vein, for example involving leaflets [61]. 
Collateral blood circulation may develop in these cases and obstruction may be overcome 
[57]. Sometimes, calf perforating veins may be an important collateral venous path when the 
popliteal vein is involved, causing CVD of a secondary etiology [57].
The initial hypertension in CVD may also be caused by valvular incompetence alone [60]. 
Varicose veins may result from endothelial changes (reduced elastin and smooth muscle con-
tent, together with increased collagen) associated with hypoxia, causing weakened venous 
tone [60]. Other changes include downregulated apoptosis [63], decrease energy for cell 
metabolism and increased lysossomal activity [64].
3.1. Etiology and anatomical location of CVD
The etiology of CVD can be described as primary, secondary (post-thrombosis) or congenital 
[13]. Although reflux is the major hemodynamic alteration in CVD, in secondary venous dis-
ease most of the cases present a mix of reflux and obstruction [58]. It seems that 80% of cases 
of CVD have a secondary etiology of post-thrombotic pathology, and 20% are of primary 
cause, as a result of valvular incompetence [57].
In the superficial system, the insufficiency is most often the result of a primary preexisting 
weakness in the vessel wall or valve, as a consequence of a direct injury, excessive venous 
distention caused by hormonal effects or high hydrostatic pressure, or secondary to venous 
obstruction (i.e., phlebitis) [33, 59, 65, 66]. Failure in valve functioning (superficial veins) may 
increase superficial venous pressure, resulting in venous dilatation and varicose veins [59]. 
Although the primary mechanism of valvular incompetence in superficial veins is not fully 
known [57], it appears that first changes in the mechanical properties of the vein wall caused 
by increased collagen content and decreased amount of elastin and smooth muscle, leading to 
vessel enlargement occur and next, valvular insufficiency develops [57].
The perforating veins can also become insufficient by primary incompetence of vein valves or 
secondary to venous obstruction [67]. In these cases, there is reflux from deep to superficial 
venous system: with valve incompetence the reflux to saphenous veins may allow the re-entry 
of venous blood to the deep venous system [67]. In the case of secondary incompetence, the 
high intravascular pressures are transmitted to superficial veins, causing the enlargement of 
dermal capillaries and increasing filtration to the interstitial space [57, 67].
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Deep veins insufficiency has been suggested to be the consequence of deep veins thrombosis 
in the majority of cases, i.e., from secondary etiology [59]. However, primary deep venous 
incompetence is also common (8-22% of the cases [12]) but is usually compensated by a strong 
muscle [12, 57]. It seems that outflow obstruction and reflux caused by valve damage may 
cause deep vein thrombosis and these two alterations together increase the probability of the 
development of post-thrombotic syndrome [12, 61].
Deep venous thrombosis may also occur because of an intrinsic venous process, such as a 
previous deep venous thrombosis episode with inadequate recanalization or venous stenosis, 
or because of extrinsic compression, as in May-Thurner syndrome [66]. Also, it can be caused 
by venous agenesis, such as in the Klippel-Trenaunay syndrome, trauma, surgical mishap, 
and tumors [57].
Congenital CVD, in which case the condition is already present at birth, also exist. However, 
this might be recognized only later in life, such as in the cases of the Klippel-Trenaunay (vari-
cosities and venous malformations, capillary malformation, and limb hypertrophy) [33] and 
Parkes-Weber (venous and lymphatic malformations, capillary malformations, and arteriove-
nous fistulas) syndromes [66].
4. Venous edema and Lymphedema
CVD is the most common cause of edema with age 50 and over  [68].  The venous edema is 
a very common clinical manifestation of CVD, particularly in C3 to C6 classes [68–72]. The 
chronic venous edema may blunt the metabolic and immunological capacity of tissues, thus 
contributing to the risk of venous ulcer [72]. Venous edema occurs when there is an imbal-
ance between vascular filtration and reabsorption and lymphatic reabsorption [19]. About 
90% of capillary filtration (proteins, plasma, and other components) is reabsorbed back to the 
blood, and the remaining 10% is reabsorbed by the lymphatic circulation [20, 73]. In CVD, 
blood filtration is increased due to the higher intravascular hydrostatic pressure and raised 
endothelial permeability due to inflammation [19, 73]. In these conditions, venous edema may 
occur [19, 20]. This is a pitting edema that gets worse through the day and improves during 
sleeping because of the lying position and leg elevation. Usually, this edema is accompanied 
by venous symptoms and signs [19, 20]. Clinically, venous edema is perceived as an increase 
in fluid volume of the skin and subcutaneous tissue, characteristically diminished by pressure 
[13]. Venous edema usually occurs around the ankle region, but may extend to the leg and 
foot [13].
The principal physiological function of the lymphatic circulation is to guarantee homeosta-
sis between the vascular and interstitial fluid compartments [74] and this requires that the 
lymphatic system compensates the excessive blood filtration at the blood capillary level [19]. 
Any failure in this process will result in accumulation of a protein rich fluid in the interstitial 
space, which is associated with an inflammatory reaction, fibrosis, overgrowth of adipose 
and connective tissue, and other symptoms that characterize the lymphedema [74]. There is 
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some evidence of lymphatic failure in venous disease. For example, studies with lymphos-
cintigraphy, reveal that in post thrombotic syndrome the subfascial lymphatic drainage is 
reduced that may explain edema and lipodermatoesclerosis seen in this situations. Also, 
patients with ulcer have reduced lymphatic drainage, suggesting that lymphedema is a con-
tributing factor to ulceration [19]. Approximately 20- 30% of individuals with CDV have 
mix edema (with venous and lymphatic component), because of fluid overload or recurrent 
cellulitis [70].
Based on the cause, the lymphedema may be classified as primary (congenital or hereditary) 
and secondary (acquire) forms [74]. Over one third of patients with CVD will have secondary 
lymphatic dysfunction but when edema is present in these patients, there is the tendency to 
misdiagnosis it as primary lymphedema [20].
When edema is at the dorsum of the foot, it is associated to squaring of the toes, thick skin, 
and is of non-pitting edema type [33]. In these cases, it is assumed that a lymphatic compro-
mise exists [33]. The lymphatic circulation may compensate for the excessive filtration, but 
lymph vessels also suffer damaged with time (microlymphoangiopathy), because of chronic 
inflammation and accompanying subcutaneous and skin lesions [20, 66]. Therefore, venous 
edema becomes compound with signs of lymphedema, with non-pitting edema and with 
hyperkeratosis, papillomatosis, most in retro and post malleolar regions an in the lateral bor-
der of the foot [19]. Clinically, this secondary lymphedema may decrease with limb elevation 
initially, but with time patients will refer aggravation of swelling in the morning and after the 
night sleep because an increased osmotic pressure in the interstitial space caused by protein 
blood extravasation [19].
5. Muscle Pump Function and dysfunction
The venous return from the periphery to the heart via the venous system is linked to the 
action of a central pump (heart and respiratory cycle), periphery venous pump, a pressure 
gradient, and competent veins and/or venous valves [43, 75].
The muscle pump refers to the hemodynamics effect of limb muscles contractions and ambu-
lation on venous circulation, which is twofold: (I) to enhance venous return from the lower 
extremity, and (II) to stimulate local blood flow and raise muscle perfusion during muscle 
contractile activity [43, 57]. The calf muscle pump has an important role for the effective 
venous return and relies on dynamic interaction between the ankle joint, muscle fascia, mus-
cles of the calf and venous valves [43, 57].
During muscle contractions, the venous blood is forced in direction to the heart and the valves 
prevent reflux during relaxation [27, 48, 76]. As deep veins are tethered to surrounding tis-
sues, muscle relaxation causes the veins to open, lead to a sudden drop in pressure within 
these vessels [58, 77, 78]. The large pressure gradient caused by the drop in deep veins hydro-
static pressure enhances blood flow from superficial to deep veins trough perforator veins, 
decreasing superficial venous pressure and enhances arterial inflow [43, 57].
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The basic concept of muscle pump operation is that the steep increase in intramuscular pres-
sure that accompanies contraction compresses the deep inner muscle veins and veins in 
the nearby inter-compartmental spaces, expressing the blood across the unidirectional vein 
valves. During muscle relaxation, intravascular pressure drops but venous blood backflow 
is prevented by the rapid closure of vein valves. Vein walls are tethered to the surrounding 
muscles and, therefore, veins are forced to open during muscle relaxation, resulting in large 
dropping of hydrostatic pressure inside the deep veins, causing aspiration of the blood flow-
ing the superficial system through the perforator veins. The decreased venous pressure due 
to the muscle pump action also raises perfusion pressure, thus leading to an increase in blood 
flow across the limb. Despite the simplicity of this model, the efficacy of the muscle pump 
relies on multiple factors and shows wide variation even among people free from venous 
dysfunction [79].
Ambulatory venous pressure (AVP) and air plethysmography are gold standard methods 
for evaluating muscle pump function (usually the foot and calf pumps together) [80, 81]. For 
ambulatory venous pressure, the conventional procedure measures the intravascular hydro-
static pressure inside a dorsal foot vein, which is then taken as proxy of the pressure in the 
veins of the lower extremity.  The percentage decrease in AVP shows large variability even in 
healthy control subjects. In a group of CVI participants, AVP decreased by approximately 75% 
at the end of ten tiptoe exercise compared to basal values, with no differences in the magni-
tude of AVP decrease between people with different CVI severities [80]. However, compared 
to healthy groups (CEAP C0 class), CVI groups show a percentage AVP decrease that on aver-
age is only approximately 35% in CEAP classes C4…C5, a value that is half of that for partici-
pants in C0 class [79]. Surely, the percentage AVP decrease plus the basal venous hydrostatic 
pressure at foot level determine the ambulatory drop in hydrostatic pressure in dorsal foot 
veins. In healthy people, the large percentage fall in AVP combines with normal basal hydro-
static venous pressure, so that in such cases mean AVP lowers to around 30 mmHg, contrast-
ing with mean AVP values >55 mmHg in C4-C6 clinical groups [79]. The AVP pressure has 
a fairly good relationship with venous incompetence, with the risk of ulceration increasing 
linearly with ambulatory venous hypertension. According to Nicolaides et al. [82], in a cohort 
of 220 CVI patients the incidence of venous-related ulcers was 0% when AVP levels were <30 
mmHg and attained 100% with AVP >90 mmHg.
The magnitude of decrease in AVP is determined by the amount of blood expressed by the 
muscular contractions but also by the rate of refilling. The time taken to elevate the pressure 
back to 90% of basal standing levels, a standard measure of recovery time (RT90), is negatively 
correlated with venous insufficiency severity, being on average >20 s in healthy people and in 
those with mild venous disease, lowering to approximately 2 s in severe clinical cases [79, 80]. 
Like for AVP, RT90 values are also predictive of the risk of ulceration [79]. Data obtained with 
air plethysmography also confirms the presence of muscle pump deficiency in CVI. Standard 
measures of air plethysmography include the ejection fraction, the venous filling index to 
90% of the basal volume, the residual volume fraction, and the venous volume [80, 83][9,12].
These muscle pump function effects have the potential to alleviate symptoms and counteract 
disability associated with chronic venous disease. The action of the muscle pump in moving 
Clinical Physical Therapy152
venous blood centrally is well described and relies on an imbricate relationship between ana-
tomical and biophysical/physiological factors of at least three separate muscle pumps: the foot, 
the calf, and the thigh muscle pumps thigh [57, 84]. The calf pump is the most important of the 
three, as a result of its larger capacitance and highest pressure-generating ability. Together, the 
foot, calf, and thigh muscle pumps assure near 90% of the venous return in the deep venous 
system of the leg [85].
5.1. Thigh muscle pump
The calf muscles, and possibly the thigh muscles, act as a pump, also called as “peripheral 
heart”, which can generate pressures of up to 300 mm Hg during exercise [86]. Nevertheless, 
it has been suggested that thigh muscle pump has a minor effect in venous return, compared 
to calf muscle pump [43, 57, 84].
The thigh muscle pump may be separated in a posterior division that includes mostly the 
semimembranous muscle, and an anterior division made up by veins from the quadriceps 
femoris muscle [32]. The veins inside the semimembranous muscle form longitudinal plexus 
that are connected in the lower part of the muscle with the popliteal vein and with the deep 
femoral vein upwards. The quadriceps femoris’ veins drain into a large trunk that often join 
the deep femoral vein to end into the common femoral vein near the root of the thigh. The 
venous valves of thigh veins may not be entirely competent thus allowing variations in the 
volume of the thigh venous reservoir to occur with posture changes [84].
5.2. Calf muscle pump
The calf muscle pump is in sequence with the foot pump is the most important muscle pump 
in the human circulatory system [27, 87]. The calf muscle pump is associated with the strong 
triceps surae muscle and can be separated in two units: a first unit that includes the soleus 
muscle (leg pump) and its veins, and a second unit situated in the upper leg region and com-
posed by the gastrocnemius muscle and respective veins (popliteal pump) [88]. The veins in 
the soleus are organized in a lateral larger group and in a medial one. The lateral veins are 
larger, run vertically and drain into the fibular veins near the superior border of the soleus 
muscle. The majority of the medial veins drain horizontally into the posterior tibial veins at 
different heights of the leg but few course vertically and laterally to join the fibular veins. The 
gastrocnemius veins take their origin from the calf perforators at the lower part of the muscle 
then giving origin to a number of pedicles that run upwards through the calf to terminate in 
a single collector draining into the popliteal vein. Through this collector the gastrocnemius 
pump powerfully ejects the blood into the popliteal vein, and anatomical variations in this 
collector are linked to differences in calf pump efficacy [88]. Calf muscles contraction can ele-
vate the pressure to approximately 140 mm Hg and increase venous blood flow through the 
popliteal and the femoral veins [32]. In competent veins, the centrifugal component during 
muscle relaxation lasts approximately 200 to 300 milliseconds and represents the physiologi-
cal reflux, in incompetent veins the duration exceeds 500 milliseconds [32].
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Less efficient calf muscle pump function (CMPF) (involving especially the gastrocnemius and 
soleus muscles) has also been related with muscle inflammation, reduced muscle oxygen sup-
ply, muscle necrosis, myofibril atrophy (muscle fibers type I and II) and muscle denervation 
[28, 29]. A study by Araki et al. [89] concluded that venous insufficiency cannot fully explain 
venous ulceration, pointing to deficient calf muscle pump as a primary factor in CVD-related 
skin and tissue damage. Several studies show that early treatment, by exercising the muscle 
pump, can prevent the most severe forms of CVD [14, 90]. The important role of CMPF on 
the progression of CVD is well established, but in many individual cases impaired calf pump 
function may go undetected until most severe changes become evident [91]. Therefore, assess-
able, accurate and non-invasive methods to evaluate CMPF are needed [30, 59, 90–92].
5.3. Foot muscle pump
The deep venous system of the foot forms a venous plexus that is composed by a lateral 
vein, a medial vein, and a deep plantar arch. The lateral and medial plantar veins are usually 
doubled and course either intramuscularly or in between the plantar muscles from a lateral 
position distally to a medial position near the ankle, where they drain into the paired poste-
rior tibial veins [93]. The deep plantar arch and the lateral and medial plantar veins receive 
blood from superficial veins located in the sole of the foot and from the metatarsal veins [85, 
93]. The plantar deep venous system is connected with the superficial veins on the dorsum of 
the foot via several perforator veins. The link between these two venous systems is specially 
well developed between the medial plantar vein and the medial marginal vein , forming what 
has been named the “medial functional unit”, which possesses the unique feature of blood 
flow being directed from deep to superficial vessels [85, 94].
The physiology of the foot pump is still not totally clear. The anatomical design of the deep 
plantar system, characterized by the presence of paired veins flanking an artery and joined 
together by connective tissue, and by the close relation between these veins, the plantar mus-
cles and the metatarsophalangeal joints, is well suited to enhance venous blood flow during 
weight bearing and ambulation. These imply that the foot pump expels the blood through a 
double mechanism: contact of the foot with the ground, resulting in extension of the tarsal 
arch and metatarsophalangeal joints associated with compression of the deep veins and the 
calcaneous plexus, and by contraction of the plantar muscles surrounding the blood reservoir 
of the deep venous system [88, 93–95]. The foot pump empties during the stance phase of the 
gait, as a result of weight-bearing, and pushing off action, and refills during the swing phase, 
when the foot is cleared from ground contact. Through its mechanisms, this pump moves 
25–30 mL of blood, equal to the capacity of the deep medial and lateral plantar veins [94]. 
Individual differences in plantar support and in the pattern of the foot muscles contraction 
during the stance phase of the gait cycle have the potential to modify the efficacy of the foot 
pump [96].
These two mechanisms (weight bearing and muscle contraction), however, do not work syn-
chronously, with plantar compression acting first then followed by the action of the muscle 
contractions at the foot [93]. These two different foot pump mechanisms may both be present 
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during the stance phase of the gait cycle, but would be active ats [93]. Also, certain clinical 
conditions of CVD could be explained by a conflict between the mechanisms of the foot pump 
and the leg pumps [97]. The knowledge about the interaction of the lower limb muscle pumps 
during contraction/relaxation as a mechanism for venous return is still quite poor [57].
5.4. Impairment of calf muscle pump and functional capacity
Calf muscle pump dysfunction might be caused by weakness of calf muscles but may also be 
related to decreased range of motion around the ankle joint during walking and other move-
ments [30, 75, 78, 98], neuropathy, muscle denervation or muscle atrophy, or gait abnormali-
ties [29, 36, 43].
Ankle function plays an important role in mobility [36]. Distal leg muscles may exhibit reduc-
tions in strength and power with aging, and these affects walking, balance, and increases the 
risk of falling [99]. Impaired ankle muscles strength has been associated with falls [100]. The 
power output by dorsiflexion muscles has been found to be closely associated with function 
in community-dwelling older women in terms of their ability to get up from and sit down on 
a chair and climb stairs [100]. Plantarflexion strength has been shown to be positively related 
to both preferred gait speed and fast gait speed [100].
Patients with CVD present limited ankle range of motion [36, 45, 47, 78, 98]. Diminished ankle 
mobility tends to aggravate as CVD progresses and in parallel with increasing severity of 
symptoms, thus further contributing to a poor CMPF [78, 98]. Together with decreased ankle 
range of motion, there is also decreased muscle strength of dorsi and plantarflexors [30, 75], 
with decreased peak torque, power ability [36], muscle resistance (number of heel rises) [45], 
and total work performed by the ankle plantarflexors [75]. Other functional alterations asso-
ciated with CVD include decreased gait speed [36, 45], decreased number of steps per week 
(in venous ulcer patients) [101], and generally impaired functional capacity and mobility [36]. 
Also, changes in ankle function alters foot pressure distribution during gait that becomes 
higher at the midfoot and lower at the toes [43].
These functional alterations, specially the decreased strength of the calf muscles and reduced 
ambulation, contribute to venous hypertension [30, 43, 46, 47, 57, 98]. Dysfunction of the mus-
cle pumps leads to venous blood not being effectively emptied out of the distal extremity [30]. 
This rarely occurs as a “primary” disorder in neuromuscular conditions or muscle wasting 
syndromes; however, clinically significant muscle pump dysfunction often occurs in severe 
reflux or obstruction [92]. Muscle pump dysfunction appears to be a major mechanism for 
the development of superficial venous incompetence and its complications, such as venous 
ulcers, and around 70% of patients with venous ulcer present calf muscle pump dysfunction 
[48, 66, 89, 91, 102].
Venous blood flow increases during calf muscle contractions in individuals with or without 
CVD. Popliteal peak flow volume is maximal during the first contraction of the tip-toe set 
of ten repetitions when the venous reservoir is full [103]. In the CVD patients, but not in 
the healthy subjects, venous flow augmentation was seen to diminish during the ten tip-toe 
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 exercise [104]. Such apparent calf pump dysfunction might be related to weak calf muscles in 
CVD patients [29, 30] and is compatible with a lower ejection volume, such as has been mea-
sured before in this population with air-plethysmography [92]. In addition, abnormal venous 
blood reflux from deep to superficial venous system through incompetent perforator veins 
may blunt blood flow through the popliteal vein [104].
Nonetheless, it seems that calf muscle size is not a strong indicator of the efficacy of muscles 
to pump venous blood during contractions in patients with venous ulcer [105]. Also, gas-
trocnemius thickness and some other muscle architectural features, like pennation angle, are 
similar in patients with low to moderate CVD severity and healthy participants, and seem 
unrelated with the severity of CVD [104]. Despite this fact, for the medial gastrocnemius, a 
few morphological parameters (like higher muscle fascicle length, and pennation angle) are 
associated with the degree of increase in peak flow velocity in the popliteal vein during tip-toe 
movement [104].
6. Clinical and functional assessment of CVD (CEAP classification, 
VCSS)
6.1. CEAP Classification
Health professionals-reported outcomes, such as VCSS and CEAP classification, are conve-
nient, easily evaluated, and relevant [15].
The CEAP classification was created to facilitate communication about CVD severity and for 
scientific research [13]. The CEAP classification was based on 1) clinical manifestations (C), 
2) etiologic factors (E), described as congenital, primary, secondary (post-thrombotic), 3) ana-
tomical distribution of disease (A), that can be located at superficial, perforator or deep veins, 
and 4) underlying pathophysiological findings (P), such as reflux, obstruction or both reflux 
and obstruction [13]. Subscripts are applied to designate S (symptomatic) from A (asymptom-
atic) limbs [65]. According to CEAP, there are six CVD categories that range from C0 to C6 
[13, 65]. Also, the N subscript indicates no evidence of disease and is applicable to E, A, and/
or P of CEAP [13, 65].
The C
0
 represents those individuals with objective evidence of venous disease (i.e., E, A, and/
or P), but with no clinical manifestations. The C
1
 is characterized by the presence of telangi-
ectasia or reticular veins (< 3mm in diameter). In the C
2
 class varicose veins (> 3 mm in diam-
eter) are present. The C
3
 distinguishes itself from the preceding categories by the presence 
of edema of venous etiology. In the C
4
 class, there are now skin trophic changes, like C
4a
, for 
pigmentation and/or eczema, and C
4b





 are associated with the occurrence of venous ulcers: the C
5
 corresponds to cases of 
prior ulceration that healed, and C
6
 to cases with active venous ulcers [13, 65].
Reticular veins, also called blue veins, subdermal varices, and venulectasies, are dilated sub-
dermal veins, usually 1 mm to less than 3 mm in diameter and with tortuous paths [13]. 
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Telangiectasias, also called spider veins, hyphen webs, and thread veins, represent the conflu-
ence of dilated intradermal venules less than 1 mm in caliber [13].
According to the guidelines, varicose veins (also called varix, varices, and varicosities [13]) 
should be palpable in an upright position and represent abnormal veins with at least 3 mm in 
diameter, [3, 13, 33]. Varicose veins can be present as a result of hypertension caused by reflux 
and/or obstruction, as discussed before [12, 57].
The development of varicose veins most frequently involves the saphenous veins, saphenous 
tributaries, or nonsaphenous superficial leg veins [13]. Varicose veins are usually tortuous, 
but tubular saphenous veins with demonstrated reflux may be classified as varicose veins 
[13].  Corona phlebectatica, also called malleolar flare and ankle flare, is commonly viewed as 
an early sign of CVD, and designates the accumulation of numerous small intradermal veins 
packed together on the medial or the lateral aspects of the ankle and foot [13].
The venous edema is a pitting edema that get worse through the day and static positions and 
improves at night with decrease hydrostatic pressure , accomplished for example in supine 
position and lower limb elevation, and usually is accompanied with venous symptoms and 
signs [19, 20].
The presence of pigmentation means that the skin becomes darker and brownish [13]. This 
results from extravasation of red blood cells into the interstitial space [57]. Blood extravasa-
tion and skin pigmentation is most noticed around the ankle, but may also be visible in the 
leg and foot [13, 106].
Atrophie blanche (white atrophy) is an induration of tissues This skin alteration, that should 
not be confused with healed venous ulcers, is usually well localized. and has the shape of a 
circular white and atrophic skin surrounded by dilated capillaries and sometimes by hyper-
pigmentation [13, 106].
Lipodermatosclerosis is also clinical sign of tissue induration, characterized by local chronic 
inflammation and fibrosis of skin and subcutaneous tissues at the lower region of the leg (also 
compromising the Achilles tendon), sometimes preceded by diffuse inflammatory edema 
of the skin, which may be painful and which often is referred to as hypodermitis [13, 106]. 
Clinically, lipodermatosclerosis must be differentiated from lymphangitis, erysipelas, or cel-
lulitis by their characteristically different local signs and systemic nature characteristics [13].
The eczema is an inflammation process, erythematous dermatitis, which may progress to 
blistering, weeping, or scaling eruption of the leg skin, and may be located anywhere in the 
leg [13, 106]. Eczema is very frequent in uncontrolled CVD, but may also be associated to 
sensitization to local therapy [13].
Venous ulcers are the worst clinical sign of CVD and represent the loss of integrity of the skin, 
with a full-thickness defect and occur most frequently near the ankle region [13], at the site 
of major perforating veins and the greatest hydrostatic pressure [66]. Venous ulcers are also 
characterized by failure to heal spontaneously and are sustained by CVD [13].
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The CEAP classification is the gold standard for classification of chronic venous disorders 
today and its use is recommended by the relevant guidelines [33]. Nevertheless, for proper 
use of CEAP some facts have to be taken into account: the CEAP classification is limited as 
a severity classification, C
2
 summarizes all kinds of varicose veins, in C
3
 it may be difficult 
to separate between venous and other reasons for edema, and corona phlebectatica is not 
included in the classification [107]. Further revisions of the CEAP classification may help to 
overcome the still-existing deficits [107]. Complementary to this classification system, some 
concepts were defined to give consistency to the scientific terms, like the CVD concept that 
designates any venous disorder associated to every clinical class, and the concept of chronic 
venous insufficiency, which represents the more severe stages of the disease (C
3-6
) [13, 65].
The CEAP classification is the gold standard for classification of chronic venous disorders 
today, and its use is recommended by the relevant guidelines [33]. Nevertheless, when using 
the CEAP system a few issues must be acknowledged: as a classifications system the CEAP 
has limitation. For example in C
3
, it may be difficult to separate between venous edema from 
edema with other causes [106].
6.2. Venous clinical severity score (VCSS)
The Venous clinical severity score (VCSS) was developed to supplement the CEAP classifica-
tion and to give an additional weight to the more severe consequences of CVD [108]. The VCSS 
score has shown good intra- and inter-observer reliability and responsiveness to change [108–
110]. This is a score that quantifies 10 items using the range: 0 (none), 1 (mild), 2 (moderate), 





, the VCSS score is reported to range between of 3–18 [111]. A worthwhile clinical improve-
ment for patients with CVD can be observed with a relative improvement of 70% in VCSS score 
[110] or with an absolute improvement of 4 points [7]. Differences between clinical classes are 
1–2 points of VCSS below C
3
, and 2–5 points above C
3
 [111]. The items of the VCSS are:
• Pain or discomfort; (i.e., aching, heaviness, fatigue, soreness, burning, with presumed ve-
nous origin), patients are asked to describe for each leg the category that best describes this 
item;
• Varicose veins (with diameter ≤ 3 mm in standing position);
• Venous edema (presumed venous origin, i.e., pitting edema present every day and with 
significant changes by standing/limb elevation or evidence of venous etiology, like varicose 
veins or history of deep vein thrombosis) - clinical staff must exam both legs and should 
ask patients about the extent of edema experienced;
• Skin pigmentation (presumed of venous origin and not including focal pigmentation over 
varicose veins or pigmentation due to other chronic diseases) - clinical staff must exam 
each leg;
• Inflammation (more than just recent pigmentation, like erythema, cellulitis, venous ecze-
ma, dermatitis);
• Induration (presumed of venous origin with secondary skin and subcutaneous changes, such 
as chronic edema with fibrosis, hypodermitis, white atrophy, and lipodermatoesclerosis);
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• Active ulcers number
• Active ulcers duration (patients are referred to describe the duration of the longest un-
healed ulcer);
• Active ulcers size (score according the size of the largest active ulcer);
• Use of compression therapy (patients should be asked about their compliance to compres-
sion therapy).
• The assessment of the items of VCSS score should be carried out for both legs.
Despite their relevance, VCSS and CEAP evaluation can be biased by observer expecta-
tions and because patient-reported outcomes are recognized by medical authorities as the 
ultimate outcome for health-care interventions, self-reported assessment of symptoms and 
HRQL is recommended for CVD as well [15, 112]. The most comprehensively validated 
scales for assessing HRQL in CVD include the chronic venous insufficiency questionnaire 
(CIVIQ), for population with CVD and without ulcer; the Aberdeen varicose vein question-
naire (AVVQ), for population with varicose veins; and the venous insufficiency epidemio-
logical and economic study on quality of life (VEINES-QOL), for population with CVD of 
all classes [113].
7. Conservative treatment of CVD
The main goals of conservative treatment for CVD, used as an adjunctive treatment or in isola-
tion, focus on both the symptoms and secondary changes of the disease, such as for instance, 
edema, skin and subcutaneous changes or ulcers [33], and the prevention of secondary com-
plications, like venous thrombosis [114]. Usually, initial treatment of CVD involves a non-
invasive conservative treatment to reduce symptoms and help prevent the development of 
secondary complications and the progression of the disease [66]. Complementary, or posteri-
orly, some interventional or surgical treatments can be undertaken [33, 66].
Behavioural education, like giving advices to raise the legs to minimize edema and reduc-
ing intra-abdominal pressure, about the right exercises, for using compressive stockings and 
proper care of the skin and wounds, together with pharmacological therapy, is the most com-
mon referred conservative treatments [33, 66]. The conservative pharmacological treatment 
with venoactive drugs may be indicated for patients with pain and edema and should be imple-
mented in association with compression for healing venous ulcers [33]. If conservative treat-
ment is unsuccessful or provides an unsatisfactory response, then further treatment, including 
surgery, should be considered based on anatomic and pathophysiological features [66].
Interventional treatments, like sclerotherapy, ablative therapy with endovenous radiofre-
quency and laser, endovascular therapy, are less invasive than surgery for treating CVD [66]. 
It has been recommended to use these techniques to treat superficial incompetence (endove-
nous thermal ablation, as laser and radiofrequency) and varicose veins (sclerotherapy) [33].
Surgical treatments are recommended in severe forms of CVD, like venous ulcers that did not 
heal after 6 months of treatment [66]. There are several surgical procedures described in the 
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literature, like ligation, stripping and venous phlebectomy, subfascial endoscopic perforator 
surgery or valve reconstruction [66].
In CVD, compression, like that provided by stockings, is recommended as a primary treat-
ment, except when patients are candidates for vein ablation, in which case compression is also 
suggested as an adjuvant treatment, particularly to prevent ulcer recurrence [33]. Compression 
therapy is recommended as a complement to surgery (like stripping), and to venoactive drug 
treatment, in order to control edema and pain, and to enhance venous ulcer healing [33].
The severity of the disease is related with the difficulty of the peripheral venous system to 
evacuate the venous blood from the periphery in the direction of the heart [33], resulting in 
venous stasis [33, 115]. Furthermore, it is assumed that there is a strict relation between blood 
flow velocity and secondary deep vein thrombosis [114]. The prevention of stasis is a main 
goal in CVD treatment and decisive in preventing venous complications and is frequently 
done through conservative approaches. Conservative CVD treatment might include intermit-
tent pneumatic compression [116], compression stockings and bandages [77, 117, 118], and 
muscle pump activation using electrical muscle stimulation [77, 119], transcutaneous electri-
cal nerve stimulation [119], or active and passive movements [103, 119]. In this regard, MLD 
maneuvers may be an alternative treatment to enhance venous flow [21–23]. Nevertheless, 
this intervention needs specialized professionals and could be an expensive health care treat-
ment. Teaching caregivers or patients simple lymphatic drainage, despite the lower efficacy 
showed in the treatment of lymphedema, when compared with MLD applied by profession-
als [25], could be an alternative.
The important role played by the ankle range of motion and calf muscle strength in the effi-
cacy of CMPF is now widely recognized [30, 36, 43, 45, 90]. Likewise, altered CMPF seems to 
play a key role in the physiopathology of CVD [30, 36, 43, 45]. Physical exercise is nowadays 
widely recommended for CVD management [90, 120]. In previously conducted randomized 
controlled trials, exercise training in patients with CVD [90] or with post-thrombotic syn-
drome [120] was shown to improve calf muscles’ peak torque at slow (60º/s) and fast (120º/s) 
speeds [90], maximal heel rise repetitions [120], CMPF [90], and HRQL [120]. However, the 
role of physical exercise in ameliorating the measures of clinical severity of CVD or in improv-
ing few performance features, such as joint range of motion or work and power ability of 
ankle plantarflexors could not be clearly demonstrated [90, 120].
8. Manual lymphatic drainage
There are four recognized techniques of MLD: the Földi [121], Vodder [122], Casley-Smith 
[123] and Leduc [124].
The four methods of MLD show some differences, but the major basic principles are very 
similar. In short, the maneuvers should be applied softly (with specific exceptions), should 
consist of a skin-stretching form of massage (not sliding), should comply with the direction of 
lymph flow, should be done using the entire hand or exceptionally with fingers, and should 
begin at the proximal regions of the extremity [122–126].
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MLD is used as a conservative treatment of lymphedema, independently of the specific 
method [127]. In the case of the Leduc method, MLD consists of a skin-stretching [127] form 
of massage that applies low pressure (<40 mm Hg) to the underlying tissues [124] along the 
anatomical distribution of the superficial lymphatic vessels and ganglions, stimulating lymph 
flow [128, 129] and the reabsorption of interstitial fluid and macromolecules through the lym-
phatic circulation [124, 128, 129]. At the lower extremity, the call-up maneuver, a technique 
belonging to the Leduc method initiates with inciting (or call-up) maneuvers in the ingui-
nal region (ganglionar stimulation) and then progresses distally along the lower extremity 
down to the edematous region, again employing call-up maneuvers, in order to stimulate 
lymph flow by enhancing the contractility of lymphagions of lymph collectors, [128, 129]. The 
reabsorption maneuver, another Leduc technique, is then applied over the edema to drain 
the interstitial fluid and soluble macromolecules through the lymphatic circulation [128–130] 
by stretching the leak filaments (connections between connective tissue to endothelial cell of 
lymphatic capillaries) when the skin is mobilized [128–130]. The whole procedure ends with 
a second round of call-up maneuvers, which are then applied in the reverse direction, ending 
at the groin region, in the case of the lower limb [128, 129]. Technically, the call-up maneuver 
initiates with the most proximal part of the hand and ends with the hands touching the skin 
while producing skin-stretching and is applied to promote the increase of lymph flow [128, 
129]. The reabsorption maneuver initiates with the most distal part of hand and ends with 
hands touching the skin while applying skin-stretching [128, 129].
8.1. Contraindications/Precautions
There are several contraindications and precautions for MLD and decongestive lymphatic 
therapy. It is suggested that cardiac, pulmonary and renal functions should be monitored 
because of temporary increase in blood flow and circulatory loading [73]. As for the contrain-
dications, the literature describes erysipelas, lymphatic systemic infection and lymphangitis, 
meaning inflammation of the lymphatic system, as absolute contraindications for MLD and 
decongestive lymphatic therapy [131]. Severe renal and heart failure are also contraindi-
cations for the use of multilayer bandages and intermittent pneumatic compression [132], 
whereas caution should be enforced when employing MLD in patients with severe cardiac 
insufficiency [128, 131, 132]. Unstable hypertension, thyroid dysfunction, hepatic cirrho-
sis with abdominal fluid (ascites), superior vena cava obstruction, untreated tuberculosis 
or malaria, are also contraindications for physical treatment [131, 132]. If swelling occurs 
for a long time after initial breast surgery, medical examination should be sought and any 
physical treatment will be stopped if inflammation occurs [132]. Also, Crohn disease, recent 
surgery, and diabetes are some additional clinical conditions that may be monitored for 
precaution [73].
8.2. Manual Lymphatic Drainage in Lymph edema
There are several indications for the use of MLD other than lymphedema, like CVD, post-
thrombotic syndrome, chronic wounds, traumatic edema (iatrogenic, postsurgical, and mus-
culoskeletal injury), complex regional pain syndrome, and lymphedema [73].
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The evidence of MLD for the treatment of edema (related to cancer or traumatic during 
sport activity, or other orthopedic injuries) [25, 26, 133] and in improving functional status 
(related to total knee arthroplasty) [24] is unclear but has been considered somehow effective, 
but more research is needed. Nevertheless, MLD might have an important role in CVD by 
improving HRQL, symptoms [134, 135], and range of motion [24] when edema/lymphedema 
is present. In palliative treatment, MLD improves pain and dyspnea [25].
Based on a systematic review, the importance of MLD for preventing the incidence of lymph-
edema is unclear [25]. A meta-analysis shows that MLD does not provide further therapeutic 
benefit in reducing lymphedema related to breast cancer, when compared to the standard 
treatment or with compression therapy [25], but another study has demonstrated a benefit 
when employing MLD in these cases [136]. However, the small benefit of MLD must be evalu-
ated together with its cost in terms of time and money spent by patients and health care sys-
tems and such cost-benefit evaluation favours the option for compression therapy by using 
multilayer bandages or compression hosiers and adding MLD only if the response to treat-
ment is unsatisfactory [136].
Lymphatic drainage employing a simpler sequence, but using the same principles as MLD, in 
a way that can be applied by patients as a self-drainage [137, 138] is less effective than MLD 
in reducing limb volume or lymphedema related to breast cancer but can be used as a more 
economical MLD option [25].
It has been also suggested that MLD, despite the augmentation of lymph flow (increasing 
lymphagion contraction and lymphatic reabsorption), might also be responsible for increas-
ing arteriolar blood flow, redirection of flow toward collateral vessels, anastomoses, and 
perhaps stimulating angionesis, but these hypothetical effects of MLD need scientific evi-
dence [73].
Younger patients, those heavier in weight and higher in body mass index are more likely to 
show poor lymphedema treatment outcome after intensive decongestive therapy [25]. When 
an elastic sleeve and multilayer bandaging are associated to MLD, there is a higher chance 
that the lymphedema treatment is successful [139].
Decongestive lymphatic therapy is the physical treatment for lymphedema by combining 
MLD with other treatments, like low-stretch bandaging and compression garments, exercise, 
and skin care, and sometimes also with intermittent pneumatic compression [30, 127, 140]. 
This method may reveal itself as effective in the treatment of lymphedema of the lower limb 
as it is for that affecting the upper limb as a result of cancer [135, 141].
Most often, decongestive lymphatic therapy is applied along two phases: the first is the edema 
reduction and intensive one, and the second one is the maintenance phase [127, 142, 143].
Decongestive lymphatic therapy is often prescribed for patients with venous ulcer and when 
CVD are associated with mixed edema (lymphatic and venous origin), now combining MLD, 
compression bandages, and stocking, physical therapy to improve calf muscle performance, 
and in few cases, intermittent pneumatic compression [16]. In the case of CVD, wearing com-
pression garments is essential for treatment efficacy [16, 143].
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8.3. Manual lymphatic drainage in CVD
8.3.1. The technique
The manual technique of MLD is not usually described in the literature. Nevertheless, based 
on research [21–23], the hands of the physical therapist must do the maneuvers producing a 
low pressures form of skin stretching. The pressure applied by the hands onto the skin and 
underlying soft tissues should be carefully adjusted to remain soft and just enough to stretch 
the skin for at least 4 s. When both legs are treated, the whole session take approximately 
40–45 min [17, 18, 21]. The duration and the number of sessions at the studies assessing the 
role MLD in CVD patients [17, 18] are similar, during 2–5 weeks, patients should complete 
10–14 sessions of MLD.
The sequence of the maneuvers follows that commonly used for lymphedema, first, moving 
from proximal to distal and, second, moving from distal to proximal [128, 129]. The maneu-
vers can be applied in the following sequence: inguinal region (10 MLD maneuvers), pro-
gressing downwards through the thigh, (30 MLD maneuvers at medial and 30 at lateral aspect 
of thigh), the popliteal region (10 MLD maneuvers applied immediately above the popliteal 
fossa and another 10 times maneuvers performed immediately below the popliteal fossa), 
downwards to the leg (30 MLD maneuvers at medial and lateral aspect of leg), and finishing 
in the dorsal aspect of the foot 30 MLD maneuvers). Next, the maneuvres should be carried 
out in the reverse order upwards: 15 maneuvers on the dorsal aspect of the foot, 15 maneuvers 
both on lateral and medial aspect of the leg, 5 maneuvers both below and above popliteal 
fossa, 15 maneuvers above both the lateral and above the medial aspect of the thigh, 5 MLD 
maneuvers on the inguinal region (Figure 1)[21]
8.3.2. Physiological effects in venous hemodynamic
Some studies suggest that MLD has an effect on blood flow in superficial veins, especially 
through the call-up maneuver [144]. Also the real impact of MLD in hemodynamics has been 
suggested to be insignificant [128]. One study concluded that 5 to 15 minutes of MLD does not 
Figure 1. Venous ultrasound assessment at popliteal vein during 1st and 10th calf contraction. Venous ultrasound 
assessment at popliteal vein during 1st (A) and 10th (B) calf contraction, during tiptoe movement for both control (no 
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change cardiac output in patients with heart failure despite the near 100% increase in venous 
return after 5 minutes of MLD [128]. Nevertheless, recent studies reveal that in real-time the 
blood flow in superficial and deep veins increase, despite the presence or absence of venous 
pathology [22, 145].
Current concepts regarding MLD indicate that each maneuver should take around 4 s from 
beginning to end [22, 23, 129]. MLD techniques, which are based on manual stretching of 
the skin and underlying soft tissues, increase venous blood flow along the superficial veins, 
as has already been suggested [144], but also along the deep venous system, which course 
beneath the deep fascia. As commonly taught, the call-up maneuver is applied in a proxi-
mal to distal direction and enhances venous blood flow. The reabsorption maneuver instead 
begins distally and then moves proximally, stimulating lymph flow and fluid reabsorption 
[129]. One study does not substantiate such differential effects between the two maneuvers 
[22]. In fact, the two maneuvers enhanced venous blood flow to a similar extent and in both 
deep (femoral vein) and superficial (great saphenous vein) veins.
The amount of strain applied to the skin and deeper tissues by MLD is not known. Although 
studies using radiolabelled tracers demonstrate the efficacy of MLD in stimulating lymph flow, 
the exact mechanisms by which these techniques work are not fully elucidated [121, 130]. Skin 
and deep fasciae are connected by ligamentous structures at the level of the thigh, knee, pop-
liteal fossa, and leg, which give stability to the skin and act like an anchor during lower limb 
movements [146]. The skin stretching applied during MLD might produce enough increase in 
pressure upon underlying structures to enhance venous flow in superficial and deep veins, as 
occurs during the physiological stretching of the skin during limb movement [147].
MLD must take into account venous anatomy and venous blood flow direction just like the 
lymphatic anatomy and the lymph flow directions, particularly when applied to larger body 
segments (like the course of GSV), such as the thigh, to be more effective in increasing venous 
flow [23, 128, 129, 145, 148].
The increased blood flow in the superficial veins would result in higher blood flow across 
perforating veins and into the deep veins, thereby raising blood flow in the deep venous 
system as well. In addition, the pressure applied to the skin, as said before, would probably 
reach the muscles underneath, and pressure would also increase in deep seated structures 
including veins, further stimulating blood flow. Also, muscle tone might increase during the 
time MLD techniques are being applied, induced by the manual stimulation, or in response to 
the movement of the lower extremity, which could have contributed to the observed increase 
in venous blood flow.
8.3.3. Therapeutic efficacy of manual lymphatic drainage for treatment of patients with chronic 
venous disease
MLD has also been used as a conservative treatment for CVD, [16], mostly when venous 
lymphedema is present [19, 20]. MLD applied before surgery in patients with CVD improves 
the clinical class of CEAP classification, HRQL, depression, anxiety, edema, and symptoms 
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[17, 18, 21]. Nevertheless, foot volumetry and reflux volume index only improve when MLD 
is associated to surgery and compression stockings [17, 18].
Previous studies show that MLD (10 sessions in 2 weeks) used in CVD patients who were 
referred to vascular surgery is effective in diminishing pain and edema and in improving 
HRQL [17]. When employed for a longer period of time (14 sessions in 5 weeks), MLD also 
seems to effectively contribute, together with surgery, to improve CVD severity [18]. However, 
such effect of MLD could be explained by faster recovery during the post-operative time. 
However, a recent study reveals that MLD (4-weeks period of MLD treatment, comprising 
ten 40 to 45 min-duration of each of 10 sessions) has a real effect in improving CVD-related 
symptoms, pain-HRQL and clinical severity (mostly related to venous edema), independently 
from vascular surgery, with the positive outcomes of MLD persisting after 1 month follow-
up [21]. Nonetheless, MLD seems to be ineffective in changing leg volume, ankle muscles 
strength, ankle active range of motion, and the physical, social or psychological components 
of HRQL of CIVIQ [21].
There is no evidence that MLD treatment may significant change ankle muscles performance 
(either during plantarflexion or during dorsiflexion) and ankle range of motion. However, the 
role of physical exercise in ameliorating the measures of clinical severity of CVD or in improv-
ing some performance features, such as joint range of motion or work and power ability of 
ankle plantarflexors, could not be clearly demonstrated [90, 120].
However, the possibility that MLD might improve ankle function during more natural activi-
ties, such as gait, has not been assessed yet.
MLD increases peripheral venous blood flow in superficial and deep veins in normal limbs 
and in those with CVD and may be an important conservative treatment for prevent blood 
stasis and its complications [21–23, 125]. The prevention of stasis, by increase venous return, 
is a main goal in CVD treatment and decisive in preventing venous complications, and there 
are several conservative approaches [114]. During the application of the MLD maneuver (with 
pressure <40 mmHg), the volume of venous blood outflow from deep and superficial veins 
increases substantially without collapsing the veins [22, 23].
Studies suggested that despite the increase of venous flow during MLD being similar in 
healthy and CVD groups (C
1_5
), in most severe cases of this disease this augmentation might 
not occur [22, 23]. CVD causes significant damage to the skin and underlying tissues. Persistent 
inflammation of the skin leads to disease complications such as lipodermatosclerosis, charac-
terized by fibrosis and microcirculatory changes [149], leg edema [27] may interfere with the 
movement of the skin and underlying soft tissues essential to MLD efficacy.
The adherence to compressive stockings is usually decisive to manage symptoms and com-
plications of CVD and venous stasis [150]. Some studies refer the importance of wearing 
compression stocking during the application of MLD [17, 18]. In one study, 23 out of the 41 
patients did not wear compression stockings and only four participants fully adhere to this 
treatment, with no influence on MLD efficacy. However two patients in the control group 
(no MLD treatment) were excluded during the study because they present deep venous 
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 thrombosis and coincidently these two participants did not comply with the use of compres-
sion stoking [21].
8.4. Recommendations for treating CVD with MLD
MLD should be applied as a low pressure, manual skin-stretching form of massage applied 
from distal to proximal throughout the lower limb, with the two hands of the physical thera-
pist placed side by side and respecting the anatomy and flow of venous vessels, in order to 
increase venous return from the lower limb in subjects with or without CVD (C
1_5
).
MLD treatment for CVD should be applied during 2–5 weeks; patients should complete 10–14 
sessions (45 min duration for both legs) of MLD. The sequence of MLD maneuvers should 
be applied proximal to distal, followed by a sequence in reverse direction (i.e., from distal to 
proximal) such as recommended for lymphedema [124, 128]. Because inflammation may be 
present in these patients, direct manual skin-stretching should be avoided over the edema, as 
for local inflammation in lymphedema. Although there is no evidence of the efficacy of MLD 
in treating venous ulcer (C
6
), it can be applied in these patients as long as no contraindications 
are present [21].
Despite no evidence that MLD prevent secondary complications associated to venous stasis, 
like venous thrombosis, the use of MLD may be an option to increase superficial and deep 
venous flow [23, 104]. In particular, MLD is recommended before venous surgery and should 
be complemented with compression stockings [17, 18].
It is recommended to use MLD to relief edema, symptoms, severity of disease, and ameliorate 
HRQL. These effects are more consistent when MLD is used as a coadjutant treatment of com-
pression stocking [17, 18, 21]. When adherence to compression treatment is difficult, MLD can 
be an option to relief symptoms and improve HRQL in patients with CVD [21].
Compromised muscle pump function, low muscle strength, and limited ankle range of motion 
can be addressed with other conservative approaches, like physical exercise.
9. Conclusion
CVD is a very common disease across the world. Despite the cosmetic issues, there are very 
important dysfunctions associated with this pathology, like muscle pump dysfunction, 
symptoms like pain, limitation of range of motions and muscle strength, gait alterations, 
Lymph(edema), higher risk of deep venous thrombosis, among other. Physical therapists 
may have an important role in assessing (using a uniformed procedure with other health pro-
fessionals) and treating these dysfunctions using a wide number of strategies, like exercise, 
Kinesio taping, and others. MLD may be an alternative coadjutant conservative treatment of 
patients with CVD, previous or not to surgery. Although there is already information about 
the importance of MLD as a treatment choice for CVD, further research is warrant to deter-
mine the best way to combine this approach with the existing CVD treating tools.
Clinical Physical Therapy166
Author details
Rute S.S. Crisóstomo1* and Paulo A.S. Armada-da-Silva2
*Address all correspondence to: crisostomo.rute@gmail.com
1 Instituto Politécnico de Castelo Branco – Escola Superior de Saúde Dr. Lopes Dias
2 Universidade de Lisboa – Faculdade de Motricidade Humana
References
[1] Writing C, Wittens C, Davies AH, Bækgaard N, Broholm R, Cavezzi A, et al., Editor's 
choice―Management of chronic venous disease. Clinical practice guidelines of the 
European society for vascular surgery (ESVS). European Journal of Vascular and 
Endovascular Surgery. 2015;49:678-737
[2] Koupidis SA, Paraskevas KI, Stathopoulos V, Mikhailidis DP. Impact of lower extremity 
venous ulcers due to chronic venous insufficiency on quality of life. The open cardiovas-
cular medicine journal. 2008;2:105-109
[3] Eklof B, Perrin M, Delis KT, Rutherford RB, Gloviczki P, American Venous F, et al. 
Updated terminology of chronic venous disorders: The VEIN-TERM transatlantic inter-
disciplinary consensus document. Journal of Vascular Surgery. 2009;49(2):498-501
[4] Boisseau MR. Leukocyte involvement in the signs and symptoms of chronic venous 
disease. Perspectives for therapy. Clinical Hemorheology and Microcirculation. 
2007;37(3):277-290
[5] Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkes FG. What are the symp-
toms of varicose veins? Edinburgh vein study cross sectional population survey. British 
Medical Journal/British Medical Association. 1999;318(7180):353-356
[6] Campbell WB, Decaluwe H, Boecxstaens V, MacIntyre JA, Walker N, Thompson JF, et al. 
The symptoms of varicose veins: difficult to determine and difficult to study. European 
Journal of Vascular Surgery. 2007;34(6):741-744
[7] Cesarone MR, Belcaro G, Rohdewald P, Pellegrini L, Ledda A, Vinciguerra G, et al. 
Improvement of signs and symptoms of chronic venous insufficiency and micro-
angiopathy with Pycnogenol: A prospective, controlled study. Phytomedicine. 
2010;17(11):835-839
[8] Darvall KA, Bate GR, Adam DJ, Bradbury AW. Generic health-related quality of life is 
significantly worse in varicose vein patients with lower limb symptoms independent of 
CEAP clinical grade. European Journal of Vascular Surgery. 2012;44(3):341-344
Manual Lymphatic Drainage in the Treatment of Chronic Venous Disease
http://dx.doi.org/10.5772/67901
167
[9] Andreozzi GM, Cordova RM, Scomparin A, Martini R, D’Eri A, Andreozzi F, et al. 
Quality of life in chronic venous insufficiency. An Italian pilot study of the Triveneto 
Region. International Angiology: A journal of the International Union of Angiology. 
2005;24(3):272-277
[10] Furtado K, Pina E, Moffatt CJ, Franks PJ. Leg ulceration in Portugal: Quality of life. 
International Wound Journal. 2008;5(1):34-39
[11] Lamping DL, Schroter S, Kurz X, Kahn SR, Abenhaim L, Evaluation of outcomes in 
chronic venous disorders of the leg: Development of a scientifically rigorous, patient-
reported measure of symptoms and quality of life. Journal of Vascular Surgery. 
2003;37(2):410-419
[12] Labropoulos N, Gasparis AP, Pefanis D, Leon LR, Jr., Tassiopoulos AK. Secondary 
chronic venous disease progresses faster than primary. Journal of Vascular Surgery. 
2009;49(3):704-710
[13] Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, Revision of 
the CEAP classification for chronic venous disorders: Consensus statement. Journal of 
Vascular Surgery. 2004;40(6):1248-1252
[14] Nullen H, Diagnosis and treatment of varicose veins: Part 1: definition, epidemiol-
ogy, etiology, classification, clinical aspects, diagnostic and indications. Der Chirurg; 
Zeitschrift für alle Gebiete der operativen Medizen. 2010;81(11):1035-46
[15] Guex JJ. Importance of patient-reported outcomes in chronic venous disorders. 
Phlebology. 2012;27(Suppl 1):136-138
[16] Steins A, Jünger, M. Physical therapy in patients with chronic venous insufficiency. 
Phlebologie. 2000;29:48-53
[17] Molski P, Kruczynski J, Molski A, Molski S. Manual lymphatic drainage improves the 
quality of life in patients with chronic venous disease: A randomized controlled trial. 
Archives of Medical Science. 2013;9(3):452-458
[18] Molski P, Ossowski R, Hagner W, Molski S. Patients with venous disease benefit from 
manual lymphatic drainage. International Angiology: A Journal of the International 
Union of Angiology. 2009;28(2):151-155
[19] Mortimer PS. Implications of the lymphatic system in CVI-associated edema. Angiology. 
2000;51(1):3-7
[20] Raju S, Furrh JBt, Neglen P. Diagnosis and treatment of venous lymphedema. Journal of 
Vascular Surgery. 2012;55(1):141-149
[21] dos Santos Crisóstomo RS, Costa DS, de Luz Belo Martins C, Fernandes TI, Armada-da-
Silva PA. Influence of manual lymphatic drainage on health-related quality of life and 
symptoms of chronic venous insufficiency: A randomized controlled trial. Archives of 
Physical Medicine and Rehabilitation. 2015;96(2):283-291
Clinical Physical Therapy168
[22] Dos Santos Crisóstomo RS, Candeias MS, Ribeiro AM, da Luz Belo Martins C, Armada-
da-Silva PA. et al. Manual lymphatic drainage in chronic venous disease: A duplex ultra-
sound study. Phlebology. 2014;29(10):667-676
[23] Crisóstomo RSS, Candeias MS, Armada-da-Silva PAS. Venous flow during manual lym-
phatic drainage applied to different regions of the lower extremity in people with and 
without chronic venous insufficiency: A cross-sectional study. Physiotherapy, 2016
[24] Ebert JR, Joss B, Jardine B, Wood DJ. Randomized trial investigating the efficacy of man-
ual lymphatic drainage to improve early outcome after total knee arthroplasty. Archives 
of Physical Medicine and Rehabilitation. 2013;94(11):2103-2111
[25] Huang TW, Tseng SH, Lin CC, Bai CH, Chen CS, Hung CS, et al. Effects of manual lym-
phatic drainage on breast cancer-related lymphedema: A systematic review and meta-
analysis of randomized controlled trials. World Journal of Surgical Oncology. 2013;11:15
[26] Vairo GL, Miller SJ, McBrier NM, Buckley WE. Systematic review of efficacy for manual 
lymphatic drainage techniques in sports medicine and rehabilitation: An evidence-based 
practice approach. The Journal of Manual and Manipulative Therapy. 2009;17(3):e80-e89
[27] Meissner MH, Moneta G, Burnand K, Gloviczki P, Lohr JM, Lurie F, et al. The hemo-
dynamics and diagnosis of venous disease. Journal of Vascular Surgery. 2007;46(Suppl 
S):4S-24S
[28] Yamaki Nozaki M, Sakurai H, Soejima K, Kono T, Hamahata A. Advanced chronic 
venous insufficiency is associated with increased calf muscle deoxygenation. European 
Journal of Vascular Surgery. 2010;39(6):787-794
[29] Qiao T, Liu C, Ran F, The impact of gastrocnemius muscle cell changes in chronic venous 
insufficiency. European Journal of Vascular Surgery. 2005;30(4):430-436
[30] Panny M, Ammer K, Kundi M, Katzenschlager R, Hirschl M. Severity of chronic 
venous disorders and its relationship to the calf muscle pump. VASA. Zeitschrift für 
Gefässkrankheiten. 2009;38(2):171-176
[31] Rowland TW, The circulatory response to exercise: role of the peripheral pump. 
International Journal of Sports Medicine. 2001;22(8):558-565
[32] Simka M, Calf muscle pump impairment and delayed healing of venous leg ulcers: Air 
plethysmographic findings. The Journal of Dermatology. 2007;34(8):537-544
[33] Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, et al. 
The care of patients with varicose veins and associated chronic venous diseases: Clinical 
practice guidelines of the society for vascular surgery and the american venous forum. 
Journal of Vascular Surgery. 2011;53(5 Suppl):2S-48S
[34] Robertson L, Evans C, Fowkers F. Epidemiology of chronic venous disease. Phlebology. 
2008;23:103-11
Manual Lymphatic Drainage in the Treatment of Chronic Venous Disease
http://dx.doi.org/10.5772/67901
169
[35] Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F, Coordinators V. 
Epidemiology of chronic venous disorders in geographically diverse populations: 
results from the Vein Consult Program. International Angiology. 2012;31(2):105-115
[36] de Moura RM, RM, Gomes Hde A, da Silva SL, Britto RR, Dias RC. Analysis of the physi-
cal and functional parameters of older adults with chronic venous disease. Archives of 
Gerontology and Geriatric. 2012;55(3):696-701
[37] Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic 
venous insufficiency and varicose veins. Annals of epidemiology. 2005;15(3):175-184
[38] Vasquez MA, Munschauer CE. Venous clinical severity score and quality-of-life assess-
ment tools: Application to vein practice. Phlebology. 2008;23(6):259-275
[39] Passman MA, McLafferty RB, Lentz MF, Nagre SB, Iafrati MD, Bohannon WT, et al. 
Validation of venous clinical severity score (VCSS) with other venous severity assess-
ment tools from the American Venous Forum, National Venous Screening Program. 
Journal of Vascular Surgery. 2011;54(6 Suppl):2S-9S
[40] Lal BK. Venous ulcers of the lower extremity: Definition, epidemiology, and economic 
and social burdens. Seminars in Vascular Surgery. 2015;28(1):3-5
[41] Sritharan K, Lane TRA, Davies AH, The burden of depression in patients with symptom-
atic varicose veins. European Journal of Vascular and Endovascular Surgery: The Official 
Journal of the European Society for Vascular Surgery. 2012;43(4):480-44
[42] Dimakakos E, Syrigos K, Scliros E, Karaitianos I. Prevalence, risk and aggravating fac-
tors of chronic venous disease: An epidemiological survey of the general population of 
Greece. Phlebology. 2013;28(4):184-190
[43] Shiman MI, Pieper B, Templin TN, Birk TJ, Patel AR, Kirsner RS. Venous ulcers: A 
reappraisal analyzing the effects of neuropathy, muscle involvement, and range of 
motion upon gait and calf muscle function. Wound Repair and Regeneration: official 
publication of the Wound Healing Society [and] the European Tissue Repair Society. 
2009;17(2):147-152
[44] Reinhardt F, Wetzel T, Vetten S, Radespiel-Troger M, Hilz MJ, Heuss D, Peripheral neu-
ropathy in chronic venous insufficiency. Muscle Nerve. 2000;23(6):883-887
[45] van Uden CJ, van der Vleuten CJ, Kooloos JG, Haenen JH, Wollersheim H. Gait and calf 
muscle endurance in patients with chronic venous insufficiency. Clinical Rehabilitation. 
2005;19(3):339-344
[46] Newland MR, Patel AR, Prieto L, Boulton AJ, Pacheco M, et al. Kirsner RS. Neuropathy 
and gait disturbances in patients with venous disease: A pilot study. Archives of 
Dermatology. 2009;145(4):485-486
[47] Dix FP, Brooke R, McCollum CN. Venous disease is associated with an impaired range 
of ankle movement. European Journal of Vascular Surgery. 2003;25(6):556-561
Clinical Physical Therapy170
[48] Kan YM, Delis KT, Hemodynamic effects of supervised calf muscle exercise in patients 
with venous leg ulceration: A prospective controlled study. Archives of surgery. 
2001;136(12):1364-1369
[49] Tsai S, Dubovoy A, Wainess R, Upchurch GR, Jr., Wakefield TW, Henke PK. Severe 
chronic venous insufficiency: Magnitude of the problem and consequences. Annals of 
Vascular Surgery. 2005;19(5):705-711
[50] Domingues EA, Cavalcanti MC, Costa PC, Lopes MH, Monteiro I, Alexandre NM. et al. 
Pain prevalence, socio-demographic and clinical features in patients with chronic ulcers. 
Journal of Tissue Viability. 2016;25(3):180-184
[51] Sandor T, Pathomechanism of chronic venous insufficiency and leg ulcer. Acta physi-
ologica Hungarica. 2004;91(2):131-145
[52] Bobridge A, Sandison S, Paterson J, Puckridge P, Esplin M. A pilot study of the develop-
ment and implementation of a ‘best practice’ patient information booklet for patients 
with chronic venous insufficiency. Phlebology. 2010;26(8):338-343
[53] Carpentier PH, Maricq HR, Biro C, Poncot-Makinen CO, Franco A. Prevalence, risk fac-
tors, and clinical patterns of chronic venous disorders of lower limbs: A population-
based study in France. Journal of Vascular Surgery. 2004;40(4):650-659
[54] Allegra C, Chronic venous insufficiency: The effects of health-care reforms on the cost 
of treatment and hospitalisation-an Italian perspective. Current medical research and 
opinion. 2003;19(8):761-769
[55] Greaney JL, Farquhar WB, Why do veins stiffen with advancing age? Journal of Applied 
Physiology. 2011;110(1):11-12
[56] Lim CS, Davies AH. Pathogenesis of primary varicose veins. The British journal of sur-
gery. 2009;96(11):1231-1242
[57] Meissner MH, Gloviczki P, Bergan J, Kistner RL, Morrison N, Pannier F, et al. Primary 
chronic venous disorders. Journal of Vascular Surgery. 2007;46(Suppl S):54S-67S
[58] Ibegbuna V, Delis KT, Nicolaides AN. Haemodynamic and clinical impact of superfi-
cial, deep and perforator vein incompetence. European Journal of Vascular Surgery. 
2006;31(5):535-541
[59] Sandor T. Chronic venous disease. A state of art. Orvosi Hetilap. 2010;151(4):131-139
[60] Bergan JJ, Pascarella L, Shmid-Schonbein GW. Pathogenesis of chronic venous dis-
ease: Insight from animal model of venous hypertension. Journal of Vascular Surgery. 
2008;47:183-192
[61] Lopez JA, Kearon C, Lee AY. Deep venous thrombosis. Hematology/the Education 
Program of the American Society of Hematology, 2004;439-456
Manual Lymphatic Drainage in the Treatment of Chronic Venous Disease
http://dx.doi.org/10.5772/67901
171
[62] Malone PC, Agutter PS. To what extent might deep venous thrombosis and chronic 
venous insufficiency share a common etiology? International Angiology: A Journal of 
the International Union of Angiology. 2009;28(4):254-268
[63] Ascher E, Jacob T, Hingorani A, Tsemekhin B, Gunduz Y. Expression of molecular medi-
ators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins. 
Journal of Vascular Surgery. 2001;33(5):1080-1086
[64] Stvrtinova V, Ferencikova J, Lysosomal enzymes and superoxide production in poly-
morphonuclear leukocytes of patients with primary varicose veins. Cor et vasa. 
1992;34(3):255-264
[65] Padberg FT, Jr. CEAP classification for chronic venous disease. Disease-a-month: DM. 
2005;51(2-3):176-182
[66] Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2005;111(18): 
2398-2409
[67] Delis KT. Perforator vein incompetence in chronic venous disease: A multivariate regres-
sion analysis model. Journal of Vascular Surgery. 2004;40(4):626-633
[68] Ely JW, Osheroff JA, Chambliss ML, Ebell MH. et al. Approach to leg edema of unclear 
etiology. Journal of the American Board of Family Medicine : JABFM. 2006;19(2):148-160
[69] Hirai M, Iwata H, Miyazaki K, Koyama A, Ikeda K, Hukiage M, et al. Effect of gaiters on 
muscle pump activity in healthy volunteers. Phlebology, 2012
[70] Raju, S, Furrh JBt, Neglen P. Diagnosis and treatment of venous lymphedema. Journal of 
vascular surgery. 2012; 55(1):141-9.
[71] Piller N. Phlebolymphoedema/chronic venous lymphatic insufficiency: An introduction 
to strategies for detection, differentiation and treatment. Phlebology. 2009;24(2):51-5
[72] Fernandez AP, Miteva M, Roberts B, Ricotti C, Rouhani P, Romanelli P. Histopathologic 
analysis of dermal lymphatic alterations in chronic venous insufficiency ulcers using 
D2–40. Journal of the American Academy of Dermatology. 2011;64(6):1123 e1-1123 e12
[73] Morgan CL. Medical management of lymphedema. In: Tretbar LI, Lee B-B, Blondeau 
B, Morgan CL, Simonian SJ, editors. Lymphedema: Diagnosis and Treatment. London: 
Springer, 2008, pp. 43-54
[74] Cueni LN, Detmar M. The lymphatic system in health and disease. Lymphatic Research 
and Biology. 2008;6(3-4):109-122
[75] Yang D, Vandongen YK, Stacey MC. Changes in calf muscle function in chronic venous 
disease. Cardiovascular Surgery (London, England). 1999;7(4):451-456
[76] Recek C. Calf pump activity influencing venous hemodynamics in the lower extremity. 
The International Journal of Angiology: Official Publication of the International College 
of Angiology, Inc. 2013;22(1):23-30
Clinical Physical Therapy172
[77] Clarke Moloney M, Lyons GM, Breen P, Burke PE, Grace PA. Haemodynamic study 
examining the response of venous blood flow to electrical stimulation of the gastroc-
nemius muscle in patients with chronic venous disease. European Journal of Vascular 
Surgery. 2006;31(3):300-305
[78] Cavalheri G, Jr, de Godoy JM, Belczak CE. Correlation of haemodynamics and ankle 
mobility with clinical classes of clinical, aetiological, anatomical and pathological clas-
sification in venous disease. Phlebology. 2008;23(3):120-124
[79] Eifell RK, Ashour HY, Lees TA. Comparison of new continuous measurements of ambu-
latory venous pressure (AVP) with conventional tiptoe exercise ambulatory AVP in rela-
tion to the CEAP clinical classification of chronic venous disease. Journal of Vascular 
Surgery. 2006;44(4):794-802
[80] Neglen P, Raju S. Ambulatory venous pressure revisited. Journal of Vascular Surgery. 
2000;31(6):1206-1213
[81] Neglen P, Raju S. Differences in pressures of the popliteal, long saphenous, and dorsal 
foot veins. Journal of Vascular Surgery. 2000;32(5):894-901
[82] Nicolaides AN, Hussein MK, Szendro G, Christopoulos D, Vasdekis S, Clarke H. The 
relation of venous ulceration with ambulatory venous pressure measurements. Journal 
of Vascular Surgery. 1993;17(2):414-419
[83] Katz ML, CA., Kerr R. Air plethysmography (APG): A new technique to evaluate patients 
with chronic venous insufficency. The Journal of Vascular Technology. 1991;1991:23-27
[84] Ludbrook J. The musculovenous pumps of the human lower limb. American Heart 
Journal. 1966;71(5):635-641
[85] Black CM. Anatomy and physiology of the lower-extremity deep and superficial veins. 
Techniques in Vascular and Interventional Radiology. 2014;17(2):68-73
[86] Gaweesh AS, Impeded venous drainage: Novel view of chronic venous disease patho-
physiology. Medical Hypotheses. 2009;73(4):548-552
[87] Alimi YS, Barthelemy P, Juhan C. Venous pump of the calf: A study of venous and mus-
cular pressures. Journal of Vascular Surgery. 1994;20(5):728-735
[88] Uhl JF, Gillot C. Anatomy of the veno-muscular pumps of the lower limb. Phlebology. 
2015;30(3):180-193
[89] Araki CT, Back TL, Padberg FT, Thompson PN, Jamil Z, Lee BC, et al. The signifi-
cance of calf muscle pump function in venous ulceration. Journal of Vascular Surgery. 
1994;20(6):872-877; discussion 8–9
[90] Padberg FT, Jr, Johnston MV, Sisto SA. Structured exercise improves calf muscle pump 
function in chronic venous insufficiency: A randomized trial. Journal of Vascular 
Surgery. 2004;39(1):79-87
Manual Lymphatic Drainage in the Treatment of Chronic Venous Disease
http://dx.doi.org/10.5772/67901
173
[91] Bradbury AW. Epidemiology and aetiology of C
4–6
 disease. Phlebology. 2010;25(Suppl 
1):2-8
[92] Nicolaides AN. Investigation of chronic venous insufficiency: A consensus statement 
(France, March 5-9, 1997). Circulation. 2000;102(20):E126-E163
[93] Corley GJ, Broderick BJ, Nestor SM, Breen PP, Grace PA, Quondamatteo F, et al. The 
anatomy and physiology of the venous foot pump. Anatomical record (Hoboken, NJ: 
2007). 2010;293(3):370-8
[94] Uhl JF, Gillot C. Anatomy of the foot venous pump: Physiology and influence on 
chronic venous disease. Phlebology. 2012;27(5):219-230
[95] Broderick BJ, Corley GJ, Quondamatteo F, Breen PP, Serrador J, Ólaighin G. Venous 
emptying from the foot: Influences of weight bearing, toe curls, electrical stimu-
lation, passive compression, and posture. Journal of Applied Physiology (1985). 
2010;109(4):1045-1052
[96] Saggini R, Bellomo RG, Iodice P, Lessiani G. Venous insufficiency and foot dysmor-
phism: Effectiveness of visco-elastic rehabilitation systems on veno-muscle system of 
the foot and of the calf. International Journal of Immunopathology and Pharmacology. 
2009;22(3 Suppl):1-8
[97] Ricci S, Moro L, Antonelli Incalzi R. The foot venous system: Anatomy, physiology and 
relevance to clinical practice. Dermatologic Surgery: Official Publication for American 
Society for Dermatologic Surgery [et al.]. 2014;40(3):225-233
[98] Back TL, TL, Padberg FT, Jr., Araki CT, Thompson PN, Hobson RW, 2nd. Limited 
range of motion is a significant factor in venous ulceration. Journal of Vascular Surgery. 
1995;22(5):519-23
[99] Webber SC, Porter MM. Reliability of ankle isometric, isotonic, and isokinetic strength 
and power testing in older women. Physical Therapy. 2010;90(8):1165-1175
[100] Suzuki T, Bean JF, Fielding RA. Muscle power of the ankle flexors predicts functional 
performance in community-dwelling older women. Journal of the American Geriatrics 
Society. 2001;49(9):1161-1167
[101] Clarke-Moloney M, Godfrey A, O’Connor V, Meagher H, Burke PE, Kavanagh EG, et al. 
Mobility in patients with venous leg ulceration. European Journal of Vascular Surgery 
2007;33(4):488-93
[102] O’Brien J, Edwards H, Finlayson K, Kerr G. Understanding the relationships between 
the calf muscle pump, ankle range of motion and healing for adults with venous leg 
ulcers: A review of the literature. Wound Practice and Research. 2012;20(2)
[103] Staubesand J, Heisterkamp T, Stege H. Use of duplex sonography to investigate the 
effect of active and passive movement at the ankle joint for promoting venous return. 
Clinical Anatomy. 1995;8(2):96-101
Clinical Physical Therapy174
[104] Crisostomo RS, Candeias MS, Armada-da-Siva PA. The use of ultrasound in the evalu-
ation of the efficacy of calf muscle pump function in primary chronic venous disease. 
Phlebology. 2014;29(4):247-256
[105] Moloney MC, Lyons GM, Egan M., Wallis F, Burke PE. Does size matter? The impact 
of calf muscle volume on venous return in patients with venous leg ulcer. Phlebology. 
2007;22:65-9
[106] Vasquez MA, MA, Rabe E, McLafferty RB, Shortell CK, Marston WA, Gillespie D, 
Revision of the venous clinical severity score: Venous outcomes consensus statement: 
Special communication of the American Venous Forum Ad Hoc Outcomes Working 
Group. Journal of Vascular Surgery. 2010;52(5):1387-96
[107] Rabe E, Pannier F. Clinical, aetiological, anatomical and pathological classification 
(CEAP): Gold standard and limits. Phlebology. 2012;27(Suppl 1):114-118
[108] Rutherford RB, Padberg FT, Jr., Comerota AJ, Kistner RL, Meissner MH, Moneta GL. 
Venous severity scoring: An adjunct to venous outcome assessment. Journal of Vascular 
Surgery. 2000;31(6):1307-1312
[109] Ricci MA, Emmerich J, Callas PW, Rosendaal FR, Stanley AC, Naud S, et al. Evaluating 
chronic venous disease with a new venous severity scoring system. Journal of Vascular 
Surgery. 2003;38(5):909-915
[110] Kakkos SK, Rivera MA, Matsagas MI, Lazarides MK, Robless P, Belcaro G, et al. 
Validation of the new venous severity scoring system in varicose vein surgery. Journal 
of Vascular Surery. 2003;38(2):224-8
[111] Lozano Sanchez FS, Carrasco Carrasco E, Diaz Sanchez S.,, Gonzalez Porras JR, 
Escudero Rodriguez JR, Marinello Roura J, Chronic venous disease in Spain: Doctor-
patient correlation. European Journal of Vascular Surgery. 2012;44(6):582-6
[112] Catarinella FS, Nieman FH, Wittens CH. The relation between clinical scores and qual-
ity-of-life in long-term follow-up. Phlebology. 2016;31(1 Suppl):99-105
[113] Launois R, Review article: Health-related quality-of-life scales specific for chronic 
venous disorders of the lower limbs. Journal of Vascular Surgery: Venous and 
Lymphatic Disorders. 2015;3:219-27.e3
[114] Morris RJ, Woodcock JP, Evidence-based compression: Prevention of stasis and deep 
vein thrombosis. Annals of Surgery. 2004;239(2):162–71
[115] Lurie F, Pevec WC, Ultrasound estimates of venous valve function in screening for 
insufficiency and following patients with chronic venous disease. The International 
journal of angiology: official publication of the International College of Angiology, Inc. 
2000;9(4):246-9
[116] Lurie F, Scott V, Yoon HC, Kistner RL. On the mechanism of action of pneumatic 
compression devices: Combined magnetic resonance imaging and duplex ultrasound 
investigation. Journal of Vascular Surgery. 2008;48(4):1000-6
Manual Lymphatic Drainage in the Treatment of Chronic Venous Disease
http://dx.doi.org/10.5772/67901
175
[117] Downie SP, Raynor SM, Firmin DN, Wood NB, Thom SA, Hughes AD, et al. Effects 
of elastic compression stockings on wall shear stress in deep and superficial veins 
of the calf. American journal of physiology. Heart and circulatory physiology. 
2008;294(5):H2112-20
[118] Partsch H, Menzinger G, Borst-Krafek B, Groiss E. Does thigh compression improve 
venous hemodynamics in chronic venous insufficiency? Journal of Vascular Surgery. 
2002;36(5):948-952
[119] Izumi M, Ikeuchi M, Mitani T, Taniguchi S, Tani T. Prevention of venous stasis in the 
lower limb by transcutaneous electrical nerve stimulation. European Journal of Vascular 
Surgery. 2010;39(5):642-5
[120] Kahn SR, Shrier I, Shapiro S, Houweling AH, Hirsch AM, Reid RD, et al. Six-month 
exercise training program to treat post-thrombotic syndrome: A randomized controlled 
two-centre trial. Canadian Medical Association Journal. 2011;183(1):37-44
[121] Tan IC, Maus EA, Rasmussen JC, Marshall MV, Adams KE, Fife CE, et al., Assessment 
of lymphatic contractile function after manual lymphatic drainage using near-infrared 
fluorescence imaging. Archives of Physical Medicine and Rehabilitation. 2011;92(5):756-
764 e1
[122] Kasseroller RG, The Vodder School: The Vodder method. Cancer. 1998;83(12 Suppl 
American):2840-2842
[123] Casley-Smith JR, Boris M, Weindorf S, Lasinski B. Treatment for lymphedema of the 
arm – The Casley-Smith method: A noninvasive method produces continued reduction. 
Cancer. 1998;83(12 Suppl American):2843-2860
[124] Leduc O, Leduc A, Bourgeois P, Belgrado JP. The physical treatment of upper limb 
edema. Cancer. 1998;83(12 Suppl American):2835-9
[125] Foldi E. The treatment of lymphedema. Cancer. 1998;83(12 Suppl American):2833-4
[126] Foldi E. Treatment of lymphedema and patient rehabilitation. Anticancer Research. 
1998;18(3C):2211-2
[127] Koul R, Dufan T, Russell C, Guenther W, Nugent Z, Sun X, et al. Efficacy of complete 
decongestive therapy and manual lymphatic drainage on treatment-related lymph-
edema in breast cancer. International journal of radiation oncology, biology, physics. 
2007;67(3):841-6
[128] Leduc O, Crasset V, Leleu C, Baptiste N, Koziel A, Delahaie C, Impact of manual lym-
phatic drainage on hemodynamic parameters in patients with heart failure and lower 
limb edema. Lymphology. 2011;44(1):13-20
[129] Lee BB, Bergan J, Rockson SG, editors. Lymphedema: A Concise Compendium of 
Theory and Practice. New York: Springer; 2011
Clinical Physical Therapy176
[130] Leduc O, Bourgeois P, Leduc AM. Manual Lymphatic drainage: scintigraphic demon-
stration of its efficacy on colloidal protein reabsorption. In: Partsh, editor. Progress in 
Lymphology IX. Excerpta Medica, Amsterdam: Elsevier; 1988
[131] Lymphoedema Framework. Management of Lymphoedema. International Consensus. 
London: MEP Ltd.; 2006
[132] Leduc O. European consensus: Rehabilitation after breast cancer treatment. The 
European Journal of Lymphology. 2008;XIX(55):13-20
[133] Majewski-Schrage T, Snyder K. The effectiveness of manual lymphatic drainage in 
patients with orthopedic injuries. Journal of Sport Rehabilitation. 2016;25(1):91-7
[134] Kim YB, Hwang JH, Kim TW, Chang HJ, Lee SG. Would complex decongestive ther-
apy reveal long term effect and lymphoscintigraphy predict the outcome of lower-
limb lymphedema related to gynecologic cancer treatment? Gynecologic Oncology. 
2012;127(3):638-42
[135] Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, A sys-
tematic review of the evidence for complete decongestive therapy in the treatment 
of lymphedema from 2004 to 2011. PM & R: The Journal of Injury, Function, and 
Rehabilitation. 2012;4(8):580-601
[136] McNeely ML, ML, Peddle CJ, Yurick JL, Dayes IS, Mackey JR. Conservative and dietary 
interventions for cancer-related lymphedema: A systematic review and meta-analysis. 
Cancer. 2011;117(6):1136-48
[137] Williams AF, Vadgama A, Franks PJ, Mortimer PS. A randomized controlled crossover 
study of manual lymphatic drainage therapy in women with breast cancer-related 
lymphoedema. European journal of cancer care. 2002;11(4):254-1
[138] de Godoy JM, Torres CA, Godoy MF. Self-drainage lymphatic technique. Angiology. 
2001;52(8):573-4
[139] Ezzo J, Manheimer E, McNeely ML, Howell DM, Weiss R, Johansson KI, et al. Manual 
lymphatic drainage for lymphedema following breast cancer treatment. The Cochrane 
Database of Systematic Reviews. 2015(5):CD003475
[140] Foeldi E, Foeldi M, Clodius L. The lymphedema chaos: A lancet. Annals of Plastic 
Surgery. 1989;22:505-15
[141] Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Christiaens MR. Different physi-
cal treatment modalities for lymphoedema developing after axillary lymph node dis-
section for breast cancer: A review. European Journal of Obstetrics, Gynecology, and 
Reproductive Biology. 2010;149(1):3-9
[142] Fialka-Moser V, Korpan M, Varela E, Ward A, Gutenbrunner C, Casillas JM, et al. The 
role of physical and rehabilitation medicine specialist in lymphoedema. Annals of 
Physical and Rehabilitation Medicine. 2013;56(5):396-410
Manual Lymphatic Drainage in the Treatment of Chronic Venous Disease
http://dx.doi.org/10.5772/67901
177
[143] The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of 
the international society of lymphology. Lymphology. 2013;46(1):1-11
[144] Leduc A, Leduc O. Drenagem linfática – teoria e prática. 2nd ed. Brasil: Manole; 2000. 
pp. 33-62
[145] Crisóstomo RS, Candeias MS, Armada-da-Silva, PA. Venous flow during manual lym-
phatic drainage applied to different regions of the lower extremity in people with and 
without chronic venous insufficiency: a cross-sectionl study. Physiotherapy. 2016.
[146] Nash LG, Phillips MN, Nicholson H, Barnett R, Zhang M. Skin ligaments: Regional 
distribution and variation in morphology. Clinical Anatomy. 2004;17(4):287-93
[147] Benjamin M, The fascia of the limbs and back-a review. Journal of Anatomy. 
2009;214(1):1-18
[148] Martin ML, Hernandez MA, Avendano C, Rodriguez F, Martinez H. Manual lymphatic 
drainage therapy in patients with breast cancer related lymphoedema. BMC Cancer. 
2011;11:94
[149] Smith PC, The causes of skin damage and leg ulceration in chronic venous disease. The 
International international journal of lower extremity wounds. 2006;5(3):160-8
[150] Ziaja D, Kocelak P, Chudek J, Ziaja K. Compliance with compression stockings in 
patients with chronic venous disorders. Phlebology. 2010;26(8):353-60
Clinical Physical Therapy178
